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648Technical factors are strongest predictors of
postoperative renal dysfunction after open
transperitoneal juxtarenal abdominal aortic
aneurysm repair
Luc Dubois, MD, Craig Durant, MD, David M. Harrington, MD, Thomas L. Forbes, MD,
Guy DeRose, MD, and Jeremy R. Harris, MD, London, Ontario, Canada
Objective: Juxtarenal abdominal aortic aneurysms (AAAs) have predominantly been repaired using an open technique. We
present a series of patients with juxtarenal AAAs and analyze multiple factors predictive of postoperative renal
dysfunction.
Methods: Between March 2000 and September 2011, all patients in our prospectively maintained database undergoing
juxtarenal AAA repair were evaluated for demographics, operative details, and in-hospital outcomes. Postoperative renal
dysfunction was classiﬁed using the RIFLE (risk, injury, failure, loss, end-stage renal disease) criteria (glomerular
ﬁltration rate decrease >25%). The relationship between perioperative factors and postoperative renal dysfunction was
explored using both univariate and multivariate analysis (logistic regression).
Results:Of 169 patients, 76 (45%) required clamping above one renal artery, whereas 93 patients (55%) required clamping
above both renal arteries. Mean (standard deviation) renal ischemia time was 29.2 (8.9) minutes (range, 12-65 minutes).
Twenty-seven patients (16%) underwent adjunctive renal procedures, 19 (11.3%) required left renal vein division, and
130 (76.9%) received intraoperative mannitol. Postoperative renal dysfunction occurred in 63 patients (37.3%), with the
majority (69%) resolving during hospital stay. Seven patients (4.1%) required postoperative dialysis, which was permanent
in two cases. Patients who developed postoperative renal dysfunction had signiﬁcantly longer mean renal ischemia times
(34.7 [9.3] minutes vs 25.9 [6.6] minutes; P < .001), a higher rate of bilateral suprarenal aortic clamping (68.3% vs
47.2%; P[ .008), higher rates of adjunctive renal artery procedures (26.7% vs 8.8%; P [ .002), and higher rates of left
renal vein division (20.6% vs 5.7%; P [ .003). Logistic regression identiﬁed left renal vein division, renal ischemia time,
and aortic clamp position as the strongest predictors of renal dysfunction. The use of mannitol was seen to be protective.
Overall in-hospital mortality was 4.1% and was 9.5% among patients with postoperative renal dysfunction.
Conclusions: Postoperative transient renal dysfunction occurred in 37.3% of patients after open juxtarenal AAA repair,
with a low incidence of dialysis and a low rate of permanent dysfunction. Technical factors including renal ischemia time,
aortic clamp position, and left renal vein division are the strongest predictors of renal dysfunction. The use of intra-
operative mannitol was associated with decreased postoperative renal dysfunction. (J Vasc Surg 2013;57:648-54.)Despite advances in endovascular aneurysm repair, jux-
tarenal abdominal aortic aneurysms (AAAs) have predomi-
nantly been repaired using an open surgical approach.
Juxtarenal aneurysms are deﬁned as aneurysms that extend
to the renal arteries and require clamping above one or
both renal arteries for repair.1 Fenestrated and branched
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://dx.doi.org/10.1016/j.jvs.2012.09.043adequate infrarenal aortic neck for traditional endovascular
aneurysm repair. In order to properly evaluate these new
therapies, a clear understanding of open surgical repair
and its limitations must be established. One of the most
important complications after juxtarenal AAA repair is post-
operative renal dysfunction. Although multiple single-
center case series have been published, these studies are
limited by variable and inconsistent deﬁnitions of postoper-
ative renal dysfunction. A recent systematic review of the
juxtarenal AAA literature recommended use of a standard-
ized system for assessment of postoperative renal dysfunc-
tion: the RIFLE (risk, injury, failure, loss, end-stage renal
disease) classiﬁcation.1 The RIFLE classiﬁcation was devel-
oped by a group of intensivists and nephrologists as a way
to standardize the assessment of acute kidney injury. It clas-
siﬁes the degree of renal dysfunction based on the change in
estimated glomerular ﬁltration rate (GFR).2 This review also
indicated that further studies are required to elucidate
optimal operative techniques and to evaluate speciﬁc renal
protective measures.1 Our objective was to address these
limitations in the current literature by applying the RIFLE
criteria to the assessment of renal dysfunction after
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technical and renal protective factors on postoperative renal
dysfunction.
METHODS
Using our prospectively maintained database, we retro-
spectively reviewed all consecutive elective open juxtarenal
AAA repairs performed at our university-afﬁliated medical
center between March 2000 and September 2011. We
deﬁned juxtarenal AAAs as those that required suprarenal
clamping, with aneurysmal extent limited to the level of
the renal arteries. We excluded type IV thoracoabdominal
aneurysms, patients with prior aortic surgery, and ruptured
aneurysms. Ethics approval was obtained from the Western
University Ethics Review Board. Patient charts and opera-
tive records were reviewed and data extracted on demo-
graphic and procedural factors.
Deﬁnitions. Demographic data including age, sex, and
medical comorbidities were extracted from the patient’s
medical record. Coronary artery disease was deﬁned as
a history of myocardial infarction, positive cardiac stress
test, or previous percutaneous or open surgical coronary
revascularization. Chronic obstructive pulmonary disease
was deﬁned as use of bronchodilator therapy or abnormal
preoperative pulmonary function tests. Peripheral vascular
disease was deﬁned as a history of claudication, ischemic
rest pain/ulceration/gangrene, or a history of previous
percutaneous or open surgical lower limb revascularization.
All patients with a history of ischemic stroke, transient
ischemic attack, or previous carotid endarterectomy were
considered to have cerebrovascular disease. Renal artery
stenosis (RAS) was deﬁned as preoperative imaging consis-
tent with RAS >50% or a history of previous renal artery
intervention for RAS. Chronic renal insufﬁciency was
deﬁned as a baseline serum creatinine >150 mmol/L.
Operative factors. All procedures were performed
using a transperitoneal and infracolic approach to the aorta,
which is the standard approach to open juxtarenal aneurysm
repair at our institution. All patients received intravenous
heparin before aortic clamping. Operative records were
reviewed anddata extracted regarding clampposition (above
one renal artery, both renal arteries, or supraceliac), renal
ischemia time (deﬁned as the time between initial suprarenal
aortic occlusion until the last renal artery was reperfused),
division of left renal vein þ/- reanastomosis in an end-to-
end fashion with running Prolene, adjunctive renal artery
procedures (renal artery reimplantation, endarterectomy, or
bypass), type of aortic graft (straight or bifurcated), esti-
mated blood loss (mL), amount of autotransfused blood
(mL), and number of blood bank transfusions (units). Renal
protective strategies including use of mannitol, furosemide,
N-acetylcysteine, and sodium bicarbonate were recorded.
No patient received cold renal perfusion.
Outcomes. Postoperative renal dysfunction was classi-
ﬁed using the RIFLE system.2 This classiﬁcation system
was developed by the Acute Dialysis Quality Initiative,
which standardized the reporting of acute renal dysfunction.
By estimating GFR using the simpliﬁed “modiﬁcation ofdiet in renal disease” (MDRD) formula (which standardizes
GFR to body surface area), changes in GFR are categorized
according to the RIFLE framework: risk (GFR decrease
>25%), injury (GFR decrease >50%), or failure (GFR
decrease>75%). Two further designations for deterioration
of kidney function over time exist: loss (complete loss of
kidney function >4 weeks) and ESKD (end-stage renal
disease with complete loss of kidney function for >3
months). Patients who met the criteria for the ﬁrst level
(>25%) were considered to have postoperative renal
dysfunction because even this degree of renal impairment
has been shown to be prognostically important for both
renal and overall patient outcomes.3 In addition, renal
dysfunction was classiﬁed as temporary if it resolved before
hospital discharge or persistent if it did not resolve before
hospital discharge. Operative mortality was deﬁned as in-
hospital death. Major complications were recorded,
including cardiac (congestive heart failure, arrhythmia,
myocardial infarction), pulmonary (pneumonia, need for
mechanical ventilation >48 hours or reintubation, pulmo-
nary embolism), and conditions requiring reoperation
(wound dehiscence, lower extremity ischemia, colonic
ischemia).
Statistical analysis. Categorical data are presented as
proportions and percentages. Continuous data are pre-
sented as mean (standard deviation). Univariate analysis
using c2 test for categorical variables and t-test for contin-
uous variables was used to identify association with postop-
erative renal dysfunction. Multivariate analysis using
logistic regression was also used to identify predictors of
postoperative renal dysfunction. The resulting logistic
regression model using postoperative renal dysfunction as
the dependent variable was evaluated using the Hosmer-
Lemeshow goodness-of-ﬁt statistic (to determine if the
model ﬁt the data over the range of predicted risk of
postoperative renal dysfunction), and inﬂuential variables
were analyzed using standardized Pearson residuals (with
sensitivity analyses excluding potential inﬂuential data
points and their inﬂuence on the conclusions of the
model). All statistical tests were two sided with signiﬁcance
set at P < .05 and were conducted using SPSS 20.0 soft-
ware (SPSS Inc, Chicago, Ill).
RESULTS
Between 2000 and 2011, 169 patients underwent open
juxtarenal AAA repair, which accounted for 8.7% of all
abdominal aortic procedures, both endovascular and open
(n ¼ 1942), at our institution over the same time period.
Baseline characteristics are summarized in Table I. Mean
AAA diameter was 6.8 (1.2) cm (range, 5-11 cm). Mean
age of patients was 72.4 (6.7) years, with males making
up 75% of the cohort. Most patients had hypertension
(95%), but less than half had a history of coronary artery
disease (42%). Preoperative renal dysfunction was only
7.1% despite a nearly 22% prevalence of RAS.
Table II summarizes the operative details. Nearly half
of the patients required clamping above both renal arter-
ies (47.9%), whereas only 12 patients (7.1%) required
Table I. Baseline characteristics of patients undergoing
open juxtarenal AAA repair
Characteristic
Total No. of patients 169
Age, mean (SD), range, years 72.4 (6.70), 52-85
Male, No. (%) 128 (75.7)
Coronary artery disease, No. (%) 71 (42.0)
Chronic obstructive pulmonary
disease, No. (%)
46 (27.2)
Smoking, No. (%) 134 (79.3)
Hypertension, No. (%) 161 (95.3)
Diabetes, No. (%) 22 (13.0)
Peripheral vascular disease, No. (%) 27 (16.0)
Cerebrovascular disease, No. (%) 18 (11.1)
Hypercholesterolemia, No. (%) 72 (42.6)
RAS, No. (%)
Unilateral 30 (17.8)
Bilateral 7 (4.1)
Preoperative GFR, mean (SD),
mL/min/1.73 m2
69 (21.5)
Preoperative creatinine,
mean (SD), mmol/L
102 (46)
Chronic renal insufﬁciency
(Cr >150 mmol/L), No. (%)
12 (7.1)
Aneurysm size, mean (SD), range, cm 6.8 (1.20), 5-11
AAA, Abdominal aortic aneurysm; GFR, glomerular ﬁltration rate; RAS,
renal artery stenosis; SD, standard deviation.
Table II. Operative details of patients undergoing
juxtarenal AAA repair
Characteristic (N ¼ 169)
Clamp position, No. (%)
Above one renal artery 76 (45.0)
Above both renal arteries 81 (47.9)
Supraceliac, No. (%) 12 (7.1)
Clamp time, mean (SD), range, minutes 29.2 (8.9), 12-65
Division of left renal vein, No. (%) 19 (11.2)
Adjunctive renal artery procedure, No. (%) 27 (16.0)
Reimplantation, No. (%) 12 (7.1)
Bypass 6 (3.6)
Endarterectomy 9 (5.3)
Mannitol, No. (%) 130 (76.9)
Furosemide, No. (%) 29 (17.2)
N-acetylcysteine, No. (%) 14 (8.3)
Sodium bicarbonate, No. (%) 19 (11.2)
Type of graft, No. (%)
Straight 117 (69.2)
Bifurcated 51 (30.8)
Estimated blood loss, mean (SD), mL 964.9 (607.1)
Cell saver blood, mean (SD), mL 424.1 (320.5)
Blood transfusion, mean, units 0.7
AAA, Abdominal aortic aneurysm; SD, standard deviation.
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patients who had signiﬁcantly diseased and calciﬁed supra-
renal and/or supramesenteric aortas with the proximal anas-
tomoses carried out at the level of the renal arteries. In two of
the 12 patients, supraceliac clamping occurred after a supra-
renal clamp had been applied in order to revise the proximal
anastomosis. In all other patients, the clamp position was
chosen before clamping, and no revisions were necessary.
Mean renal ischemia time was 29.2 (8.9) minutes (range,
12-65 minutes). Division of the left renal vein was required
in 19 patients (11.2%), with the vein reanastomosed in all
but two patients. Division of the left renal vein was planned
in all but one case in order to improve exposure; when per-
formed, the left adrenal and gonadal veins were preserved.
No follow-up imaging was obtained to document whether
or not the reanastomosed renal vein remained patent.
Adjunctive renal procedures were required in 27 patients
(16%): renal artery reimplantation in 12, renal artery bypass
in six, and renal endarterectomy in nine. Over two-thirds of
patients (69.2%) were repaired with a nonbifurcated aortic
graft. Average estimated blood loss was 965 mL. Of the
patients, 74.5% requiredonly autotransfused cell saver blood,
and the average number of blood transfusions was 2.6 units
among those who received blood bank transfusions. The
most common renal protective medication given was
mannitol, which was used in 130 patients (76.9%) at an
average dose of 0.5 g/kg (range, 0.1-1.0 g/kg). Other
potentially renal protective medications, including furose-
mide, N-acetylcysteine, and sodium bicarbonate, were used
infrequently. No patients received renal-dose dopamine
during the procedure.The overall rate of postoperative renal dysfunction was
37.3% (n ¼ 69), with 55.6% of these patients classiﬁed as
having mild renal dysfunction (RIFLE class 1), 28.6%
moderate renal dysfunction (RIFLE class 2), and 15.9%
severe renal dysfunction (RIFLE class 3). In the majority
of cases, the renal dysfunction was temporary (resolved
during hospital stay). Only 30.2% of patients had renal
dysfunction that persisted to discharge. Seven patients
required dialysis, which was temporary in the majority of
cases (5/7). The rate of renal dysfunction among patients
with an aortic clamp placed above one renal artery was
26.3% (20/76), above both renal arteries was 42.0% (34/
81), and to the supraceliac aorta was 75% (9/12). The in-
hospital mortality rate was 4.1% (n ¼ 7). Two patients
died of cardiac complications within the ﬁrst week, and
the remaining ﬁve patients died after prolonged stays in
the intensive care unit and respiratory failure. The mortality
rate was signiﬁcantly higher among those with postoperative
renal dysfunction (9.5% vs 1.0%). Other complications
occurred in 32.1% of patients, with the majority of these
being cardiac and respiratory in nature (Table III).
Patients with postoperative renal dysfunction had
longer renal ischemia times, a higher proportion of bilateral
suprarenal clamping, a higher rate of left renal vein division,
more adjunctive renal artery procedures, and greater oper-
ative blood loss than did patients without renal complica-
tions (Table IV). Logistic regression identiﬁed several
intraoperative factors as being predictive of postoperative
renal dysfunction. Longer renal ischemia time (odds ratio
[OR], 2.1 per each additional 5 minutes; 95% conﬁdence
interval [CI], 1.5-2.8), bilateral suprarenal clamping (OR,
2.4; 95% CI, 1.0-6.0), and left renal vein division (OR,
5.6; 95% CI, 1.6-19.6) all were independent predictors
of postoperative renal dysfunction. Preoperative factors
Table III. Clinical outcomes of patients undergoing
juxtarenal abdominal aortic aneurysm repair
Characteristic (N ¼ 169)
Renal dysfunction (RIFLE class)
Total 63 (37.3)
Class 1 (GFR decrease >25%) 35 (55.6)
Class 2 (GFR decrease >50%) 18 (28.5)
Class 3 (GFR decrease >75%) 10 (15.9)
Transient 44 (69.8)
Persistent 19 (30.2)
Dialysis 7 (4.1)
In-hospital mortality 7 (4.1)
Any complication 54 (32.1)
Arrhythmia 11 (6.5)
Congestive heart failure 14 (8.3)
Myocardial infarction 6 (3.6)
Prolonged mechanical ventilation (>48 hours) 11 (6.5)
ARDS/pneumonia 4 (2.4)
Pulmonary embolus 2 (1.2)
Wound dehiscence 2 (1.2)
Lower extremity ischemia (embolectomy) 1 (0.6)
Colonic ischemia requiring bowel resection 2 (1.2)
Upper GI bleed 1 (0.6)
Hospital stay, median (interquartile range), days 8 (6-11)
ARDS, Acute respiratory distress syndrome; GFR, glomerular ﬁltration rate;
GI, gastrointestinal; RIFLE, risk, injury, failure, loss, end-stage renal disease.
Values are given as number (%) unless otherwise indicated.
Table IV. Comparison of preoperative and operative
characteristics between patients with and those without
postoperative renal dysfunction
Group
Renal
dysfunction
No renal
dysfunction P value
N 63 106
Preoperative renal
dysfunction, No. (%)
3 (4.8) 9 (8.5) .364
RAS, No. (%) 17 (27.0) 22 (20.8%) .373
Age, mean (SD), years 72.8 (6.8) 72.2 (6.7) .588
Diabetes, No. (%) 12 (19.0) 10 (9.4) .073
Aneurysm size, mean (SD), cm 6.9 (1.1) 6.8 (1.3) .770
Clamp time,
mean (SD), minutes
34.7 (9.3) 25.9 (6.6) <.001
Clamp position, No. (%)
Above one renal artery 20 (31.7) 56 (52.8) .008
Above both renal arteries 43 (68.3) 50 (47.2)
Left renal vein division, No. (%) 13 (20.6) 6 (5.7) .003
Adjunctive renal procedure,
No. (%)
16 (25.4) 9 (8.5) .002
Estimated blood loss, mean,
mL
1228.6 808.11 <.001
Mannitol, No. (%) 45 (71.4) 85 (80.2) .191
Complications, No. (%) 31 (49.2) 25 (23.6) .001
Death, No. (%) 6 (9.5%) 1 (1.0) .011
RAS, Renal artery stenosis.
Table V. Logistic regression of factors predicting
postoperative renal dysfunction
Variable OR (95% CI) P value
Age 1.0 (0.9-1.1) .15
Preoperative renal dysfunction 0.5 (0.1-3.4) .51
Diabetes 1.9 (0.6-5.9) .25
Estimated blood loss (per 100 mL) 1.1 (1.0-1.2) .07
Clamp position 2.4 (1.0-6.0) .05
Renal ischemia time (per 5 minutes) 2.1 (1.5-2.8) <.001
Left renal vein division 5.6 (1.6-19.6) .008
Mannitol 0.3 (0.1-0.8) .02
Renal procedure 2.0 (0.6-6.2) .24
RAS 0.9 (0.4-2.6) .96
Aneurysm size 0.9 (0.6-1.2) .40
CI, Conﬁdence interval; OR, odds ratio; RAS, renal artery stenosis.
Hosmer-Lemeshow goodness-of-ﬁt test (4.3, df 8, P ¼ .83).
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dysfunction, and diabetes were not predictive of postoper-
ative renal dysfunction (Table V).
The only renal protective factor identiﬁed was the use of
intraoperative mannitol (OR, 0.3; 95% CI, 0.1-0.8), which
was typically given as a single dose before aortic clamping
(average dose of 0.5g/kg). The frequency of mannitol use
did not differ among surgeons. Fig 1 shows the relationship
between renal ischemia time, use of mannitol, and predicted
probability of postoperative renal dysfunction. The ﬁgure
demonstrates that the effect of mannitol appeared to be
reasonably consistent over the range of renal ischemia times
(parallel curves of the mannitol and non-mannitol groups).
A similar effect can be seen among patients with left renal
vein division, among whom the risk of postoperative renal
dysfunction was systematically higher regardless of renal
ischemia time (Fig 2).
Themodel was evaluated using several diagnostic proce-
dures. All potential interactions were evaluated, and none
were found to be signiﬁcant. The model “ﬁt” the data
well with a nonsigniﬁcant Hosmer-Lemeshow goodness-
of-ﬁt test (P ¼ .83). Analysis of the Pearson standardized
residuals revealed no inﬂuential points that invalidated the
results of the model.
DISCUSSION
Using the RIFLE criteria, the rate of postoperative renal
dysfunction after open juxtarenal AAA repair in this series
of patients was 37%, with the majority being mild and tran-
sient in nature. This is consistent with the published litera-
ture, where rates range from 0 to 39% (median, 18%) asdemonstrated in a recent systematic review of studies using
varying deﬁnitions of renal dysfunction.1 The proportion of
patients requiring dialysis in this study was 4.1%, with only
two of seven patients requiring permanent renal replace-
ment therapy. Similar to our ﬁndings, West et al4 reported
a series of 247 patients with pararenal aneurysms and found
that 80% of patients with postoperative renal dysfunction
recovered by the time of discharge. In a similar study,
Jean-Claude et al5 reported on 257 pararenal aneurysms
with postoperative renal dysfunction recovery or improve-
ment in 75% of their patients. Other studies have also iden-
tiﬁed similarly low rates of permanent dialysis after open
juxtarenal AAA repair.5-9
Fig 1. Relationship between renal ischemia time (clamp time) and
predicted probability of renal dysfunction in patients with and
those without mannitol use.
Fig 2. Relationship between renal ischemia time (clamp time) and
predicted probability of renal ischemia in patients with and those
without left renal vein division.
JOURNAL OF VASCULAR SURGERY
652 Dubois et al March 2013The in-hospital mortality rate in this study of 4.1%
compares favorably with other reports in the literature.5,6,8-10
However, despite the transient nature of postoperative renal
dysfunction in the majority of cases, it remains a signiﬁcant
prognostic factor, as the mortality rate among those with
renal dysfunction was signiﬁcantly higher than in those
without (9.5% vs 1%). This association between postopera-
tive renal dysfunction and mortality has been seen in studies
using the RIFLE criteria in other populations.3 Given its
impact on prognosis, the risk of postoperative renal dysfunc-
tion needs to be minimized in patients undergoing AAA
repair.
In this study, we identiﬁed several technical factors as
being predictive of postoperative renal dysfunction. With
every additional 5 minutes of renal ischemia time, the risk
of postoperative renal dysfunction doubled (OR, 2; 95%
CI, 1.5-2.8). Clamping above both renal arteries (as
opposed to clamping the aorta between the renal arteries)
resulted in a doubling of the risk of postoperative renal dys-
function (OR, 2.4; 95% CI, 1.0-6.0). Finally, left renal vein
division increased the risk of postoperative renal dysfunc-
tion nearly sixfold (OR, 5.6; 95% CI, 1.6-19.6).
Previous studies of the effects of renal ischemia time
had suggested a threshold effect, with an increased risk
of renal dysfunction occurring when the kidneys had
been ischemic for 30 to 45 minutes.6,11,12 Our results
suggest a linear relationship between renal ischemia time
and the likelihood of postoperative renal dysfunction
(Fig 1). This concept that increasing renal ischemia time
equates to an increased risk of postoperative renal dysfunc-
tion is supported by West et al,4 who also identiﬁed anincreased risk of renal dysfunction for each additional
5-minute interval of renal ischemia. When examining the
relationship between predicted probability of renal
dysfunction and ischemia time, according to our model,
the doubling in risk of renal dysfunction appears to begin
at roughly 22 minutes of renal ischemia time. In contrast,
Sarac et al9 described 138 patients undergoing juxtarenal
AAA repair and did not ﬁnd increasing renal ischemia
time to be predictive of postoperative renal dysfunction.
This ﬁnding may have been confounded by the common
use of supravisceral aortic clamping (supraceliac or supra-
mesenteric) in their study, where patients with a supravisc-
eral clamp had higher rates of renal dysfunction despite
shorter renal ischemia times when compared with supra-
renal clamping. In addition, retroperitoneal exposure was
used in nearly 60% of patients, and no patients required
left renal vein division. Retroperitoneal exposure allows
access to the suprarenal aorta without having to manipu-
late the left renal vein and is a strategy to avoid its
division.
The published literature is not universal in demon-
strating that aortic clamp position is predictive of postoper-
ative renal dysfunction, with resulting controversy
surrounding the optimal clamp position during pararenal
or juxtarenal aneurysm repair. The debate centers on the
added risk of visceral and mesenteric ischemia with supra-
celiac aortic occlusion vs the increased risk of embolization
and atherosclerotic plaque disruption associated with
clamping of a diseased suprarenal aorta. Knott et al6
reported on 126 patients with juxtarenal AAA repair and
found no signiﬁcant difference in the rate of postoperative
JOURNAL OF VASCULAR SURGERY
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renal (above one renal only), or supravisceral clamp posi-
tions. This may be partially accounted for by the use of
different outcome criteria, a lower overall rate of renal
dysfunction (18%), and a smaller sample size. Given these
circumstances, it would be more difﬁcult to detect a rela-
tionship between aortic clamp position and postoperative
renal dysfunction. Similarly, Jean-Claude et al5 also failed
to identify a relationship between aortic clamp position
(suprarenal vs supravisceral) and postoperative renal
dysfunction. However, in this study, there was a high
correlation between supravisceral aortic occlusion and the
need for adjunctive renal artery procedures, which may
have obscured the potential relationship between aortic
clamp position and renal dysfunction.5 Finally, Shortell
et al8 described 112 patients undergoing juxtarenal AAA
repair and failed to identify an increase in complications
with supraceliac clamping; however, because it was used
in >80% of patients, any comparison with suprarenal aortic
clamp position likely is unbalanced and underpowered.
In this study, we identiﬁed aortic clamp position as
being prognostically signiﬁcant. Placement of an aortic
clamp between the renal arteries and therefore maintaining
constant perfusion to one kidney did result in a decreased
incidence of postoperative renal dysfunction. This relation-
ship retained its signiﬁcance after adjustment for other
potential contributing factors, such as renal ischemia time
and adjunctive renal artery procedures. Unfortunately,
not all patients will be anatomic candidates for this
approach due to aneurysm extent and degree of aortic
calciﬁcation/thrombus. However, it appears that selecting
the “best” aortic clamp position and preserving blood ﬂow
to as many visceral vessels as possible during juxtarenal
AAA repair are important in mitigating the risk of postop-
erative renal dysfunction.
Left renal vein division was also found to be a signiﬁ-
cant independent predictor of postoperative renal dysfunc-
tion, despite anatomic reconstruction in 90% of cases. It is
possible that the requirement for left renal vein division is
a surrogate marker indicative of a more complex aneurysm
repair, as opposed to a true contributor to postoperative
renal dysfunction. Using our model, we attempted to
account for most other factors that might be associated
with a more complicated aneurysm repair (renal ischemia
time, aortic clamp position, adjunctive renal artery proce-
dures, intraoperative blood loss). Left renal vein division
remained a strong predictor of postoperative renal
dysfunction. The co-effects of left renal vein division and
renal ischemia time are illustrated in Fig 2. It appears
that the added insult to the left kidney from interruption
of venous outﬂow (temporary or permanent) is detrimental
to postoperative renal function and therefore should be
avoided if at all possible. This ﬁnding is supported in the
literature by West et al,4 who also found left renal vein divi-
sion to be a signiﬁcant independent predictor of renal
dysfunction during pararenal AAA repair. It is unfortunate
that we do not have consistent subsequent imaging on these
patients, because perioperative left renal vein thrombosismay have contributed to the documented increased risk of
postoperative renal dysfunction.
Adjunctive renal artery procedures (endarterectomy,
bypass, or reimplantation) were required in 16% of our
patients. There was an association with postoperative renal
dysfunction at the univariate level, but this failed to retain
its signiﬁcance with multivariate analysis. It is hypothesized
that other factors such as renal ischemia time, aortic clamp
position, and left renal vein division exert a much stronger
effect on renal dysfunction than adjunctive renal artery
procedures. West et al4 identiﬁed the need for renal artery
bypass as being predictive of postoperative renal dysfunc-
tion, suggesting that renal endarterectomy or re-
implantation are preferable alternatives if anatomically
possible.
Patients with postoperative renal insufﬁciency also had
greater blood loss compared with those who did not,
although this association lost its signiﬁcance during
multivariable analysis. Increased blood loss can lead to
further reduction in intravascular volume, thus affecting
postoperative renal function, but it is also a surrogate for
a more technically challenging repair. This likely explains
why it is not a signiﬁcant predictor when analyzed along-
side other technical factors in the model. Preoperative renal
insufﬁciency has consistently been shown to be a risk factor
for postoperative renal dysfunction in patients with juxtare-
nal aneurysms.5,6,9 However, our model did not identify
preoperative renal dysfunction as being a signiﬁcant
predictor of postoperative renal dysfunction. Our patients
had a relatively low rate of preoperative renal insufﬁciency
(7%) compared with other studies in the literature. In
patients with well-preserved preoperative renal function,
technical factors become the key determinants of postoper-
ative renal dysfunction. In addition, the majority of patients
(60%) who had preoperative renal dysfunction also had
RAS, which was a variable in the model and may have
further confounded the effect of preoperative renal
dysfunction on postoperative renal dysfunction.
The most common method of renal protection used in
this series was intraoperative administration of mannitol
(77%). It was seen to be protective with an associated
reduction in the risk of postoperative renal dysfunction
(OR, 0.3; 95% CI, 0.1-0.8). Mannitol is an antioxidant
that protects the kidney from reperfusion injury13 and an
osmotic diuretic that protects against renal cellular swelling
associated with ischemia.14 Despite its widespread use in
patients with juxtarenal aneurysms,6,7,9,11,15,16 no conclu-
sive evidence of its protective effect exists.17 To our knowl-
edge, this is the ﬁrst study to document a beneﬁt of
mannitol in patients undergoing open juxtarenal AAA
repair in terms of reducing postoperative renal dysfunction.
Other pharmacologic agents for perioperative renal protec-
tion, such as furosemide, N-acetylcysteine, and sodium
bicarbonate, were used too infrequently to be properly
evaluated.
Our study is limited by the retrospective nature of the
data collection and its single-center origin. This resulted in
a select population of patients with relatively well-preserved
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654 Dubois et al March 2013preoperative renal function. In addition, although we
accounted for many preoperative factors that could inﬂu-
ence postoperative renal dysfunction, it is possible that
residual confounders (eg, preoperative use of diuretics,
preoperative volume status) that were not accounted for
may have inﬂuenced our results. In addition, we do not
have data on the speciﬁc quality of the aorta (thrombus
load, calciﬁcation) at both the anastomotic and clamping
sites. Differences in the quality of the aorta may have
inﬂuenced our conclusions, as this likely affected the tech-
nical difﬁculty of aneurysm repair and the rate of renal
dysfunction. Despite these limitations, this is the ﬁrst study
to apply the RIFLE criteria to the assessment of postoper-
ative renal dysfunction in patients undergoing open jux-
tarenal AAA repair. We used multivariate analysis with
appropriate model diagnostics (goodness-of-ﬁt testing,
assessment of residuals and inﬂuential points) to identify
independent predictors of postoperative renal dysfunction.
The use of rigorous statistical methods and standardized
assessment of outcomes allowed us to make substantive
conclusions about perioperative factors and postoperative
renal dysfunction.
CONCLUSIONS
Postoperative renal dysfunction, as classiﬁed by the
RIFLE criteria, is common after open juxtarenal AAA
repair. Fortunately, it is mild and transient in the majority
of cases, with an extremely low rate of new-onset perma-
nent dialysis. Patients with juxtarenal AAAs can be success-
fully treated with open surgical repair, with low overall
mortality and infrequent permanent renal morbidity. These
ﬁndings should be taken into account in the ongoing eval-
uation of advanced endovascular repair. Renal protective
strategies should include consideration of technical factors
such as minimization of renal ischemia time, optimization
of aortic clamp position, and avoidance of left renal vein
division as well as pharmacologic adjuncts such as adminis-
tration of intraoperative mannitol.
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